FDA Approves Oral Hormone Therapy for Treating Advanced Prostate Cancer

via investmart007    Discuss    Off Beat News
(STL.News) Friday, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. “Today’s approval marks the first oral drug in this class and it may eliminate some patients’ need to visit the clinic for treatments that require administration by a health...

Submit a Comment

Log in to comment or register here